Search

everythinglearnresearchcommunity

for

Search:↓

Keloid skin disorder involves abnormal fibroblast activation and immune response, linked to a group of genes including FGF11.

Targeting Midkine can help reduce pain and itching in keloids.

Spontaneous keloids may be linked to nephrogenic systemic fibrosis in dialysis patients.

IGF2BP3 gene is up-regulated in keloid patients, suggesting potential targets for treatment.

Low-dose radiation and certain drugs can inhibit keloid growth, revealing potential treatment targets.

Keloid fibroblasts cause itch and pain by releasing more histamine.

Dermatoscopy helps track scar changes and guide treatment.

Schwann cell and M2 macrophage interactions contribute to keloid growth by increasing matrix deposition.

Non-surgical treatments can significantly reduce keloids in children, with combination therapies being safer and more effective.

Three genes, BMP4, POSTN, and WNT5A, may help treat keloids.

Mechanical tension worsens keloid scars by activating inflammation and fibrosis pathways.

Blocking the HEDGEHOG-GLI1 pathway can reduce keloid growth and may be a potential treatment.

Itchy keloids on the chest are linked to more nerve fibers and substance P.

Combining TCA with 5-FU is more effective and safer for treating keloids than TCA alone.

High levels of NEDD4-TV3 and IGF-1 may predict and contribute to keloid formation.

Targeting the HEDGEHOG-GLI1 pathway could help treat keloids.

Using lidocaine before keloid injections makes the treatment more comfortable for patients.

Keloids are strongly linked to atopic dermatitis and other health issues.

Newer techniques like FUE and SMP reduce scarring in hair transplants.

Pre-sternal keloids are more common in males and can be effectively treated with injections, though recurrences may need more treatment.

Different fibroblasts play key roles in skin healing and scarring.

Skin problems can be caused or worsened by physical forces and pressure on the skin.

IL-1 promotes fat cell growth in skin, while WNT inhibits it and encourages scar formation.

Minoxidil affects collagen-related genes, potentially helping treat fibrosis.

Laser therapy on darker skin has higher risks and needs expert handling.

MicroRNA-21 could help diagnose and treat skin fibrosis.

Wounds heal without scarring in early development but later result in scars, and studying Wnt signaling could help control scarring.

Tiny vesicles from stem cells could be a new treatment for healing wounds.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.